1327 Jones Drive
Email: sales @ genomenon.com
About GenomenonGenomenon develops software tools to rapidly and autonomously prioritize data points for decision-making, revolutionizing the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians and researchers to quickly, and accurately, identify disease-causing variants from genomic-sequencing datasets.
CEO: Mike Klein
Co-Founder and CSO: Mark J. Kiel MD, PhD
Co-Founder and CTO: Steve Schwartz
Co-Founder: Kojo S.J. Elenitoba-Johnson MD
Co-Founder: Megan S. Lim MD, PhD
Please click here for Genomenon's job opportunities.
Please click here for Genomenon's products.
6 articles with Genomenon
The grant is the latest in a steady stream of company advances highlighted by the addition of a chief financial officer in January and several collaborative agreements in the past year.
BioIT World Conference Highlights: Altos and WASAI, Genomenon and Google, 1CellBio and More
4/18/2019The BioIT World Conference & Expo is going on in Boston, Massachusetts, highlighting companies and breakthroughs working on the data end of life sciences, whether that’s blockchain, artificial intelligence, machine learning, data science, deep learning or others.
Investments from Merck KGaA, Beacon Pharmaceuticals and Genomenon will provide new jobs for local economies.
Genomenon Announces The Next Advance In Genomic Interpretation
Genomenon Wins $1.8M NIH Grant To Automatically Curate Genomic Literature
Genomenon Delivers Evidence-Based Gene Panel Designs